GLPBio

MELK

MELK (maternal embryonic leucine zipper kinase) is an enzyme that interacts with CDC25B.

Products Related to MELK(8)

  • GC10201 structure
    GC10201OTSSP167
    CAS: 1431697-89-0
    Purity: >98%

    MELK inhibitor

  • GC12155 structure
    GC12155OTSSP167 hydrochloride
    CAS: 1431698-10-0
    Purity: >99.50%

    MELK inhibitor,highly potent and selective

  • GC25626 structure
    GC25626MELK-8a Dihydrochloride
    CAS: 1922153-17-0 (free base)
    Purity: >98%

    MELK-8a Dihydrochloride is a novel inhibitor of maternal embryonic leucine zipper kinase (MELK) with an IC50 of 2 nM.

  • GC32736 structure
    GC32736MELK-8a hydrochloride
    CAS: 2096992-20-8
    Purity: >98.00%

    MELK-8a hydrochloride is a novel maternal embryonic leucine zipper kinase (MELK) inhibitor with an IC50 of 2 nM.

  • GC32995 structure
    GC32995JNJ-47117096 hydrochloride (MELK-T1 hydrochloride)
    CAS: 1610536-69-0
    Purity: >98.00%

    JNJ-47117096 hydrochloride (MELK-T1 hydrochloride) is potent and selective MELK inhibitor, with an IC50 of 23 nM, also effectively inhibits Flt3, with an IC50 of 18 nM.

  • GC66065 structure
    GC66065MELK-IN-1
    CAS: 2095596-44-2
    Purity: >98%

    MELK-IN-1 is a potent inhibitor of maternal embryonic leucine zipper kinase (MELK) with an IC50 and a Ki of 3 nM and 0.39 nM, respectively.

  • GC69242 structure
    GC69242HTH-01-091
    CAS: 2000209-42-5
    Purity: >98%

    HTH-01-091 is a potent and selective inhibitor of maternal embryonic leucine zipper kinase (MELK), with an IC50 of 10.5 nM. HTH-01-091 also inhibits PIM1/2/3, RIPK2, DYRK3, smMLCK and CLK2. HTH-01-091 can be used for breast cancer research.

  • GC72931 structure
    GC72931HTH-01-091 TFA
    Purity: >98.00%

    HTH-01-091 TFA is a potent and selective maternal embryonic leucine zipper kinase (MELK) inhibitor, with an IC50 of 10.5 nM.